Author:
Chaiteerakij Roongruedee,Ariyaskul Darlene,Kulkraisri Kittipat,Apiparakoon Terapap,Sukcharoen Sasima,Chaichuen Oracha,Pensuwan Phaiboon,Tiyarattanachai Thodsawit,Rerknimitr Rungsun,Marukatat Sanparith
Funder
The Second Century Fund (C2F), Chulalongkorn University
Digital Economy and Society Development Fund, Office of the National Digital Economy and Society Commission, Ministry of Digital Economy and Society, Thailand; National Research Council of Thailand
Thailand Science research and Innovation Fund Chulalongkorn University
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Harris, P. S. et al. Hepatocellular carcinoma surveillance: An evidence-based approach. World J. Gastroenterol. 25(13), 1550–1559 (2019).
2. Neuzillet, C. et al. Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French association for the study of the Liver (AFEF). Liver Int. https://doi.org/10.1111/liv.15948 (2024).
3. Khan, S. A., Toledano, M. B. & Taylor-Robinson, S. D. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB 10(2), 77–82 (2008).
4. Massarweh, N. N. & El-Serag, H. B. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control. 24(3), 1073274817729245 (2017).
5. Singal, A. G. et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 78(6), 1922–1965 (2023).